AT1R-mediated NIR-II/PA imaging-guided iCM exosome therapy for myocardial ischemia revascularization
A theranostic platform based on a dual-modality near-infrared II fluorescence and photoacoustic imaging probe targeting the angiotensin II type 1 receptor (AT1R) establishes a multifunctional platform that integrates diagnosis and therapy, providing a promising strategy for the precise management of MI/RI.